|
The Impact of COVID-19 on Pulmonary Procedures
RECRUITINGSponsored by M.D. Anderson Cancer Center
Actively Recruiting
SponsorM.D. Anderson Cancer Center
Started2020-11-11
Est. completion2027-02-02
Eligibility
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT05022446
Summary
This study investigates the changes in practice by pulmonary procedural programs across the United States as they faced the coronavirus pandemic. Information gathered from this study may help guide pulmonary programs on a wider scale and improve their practice. The study may also help researchers understand where they should focus research efforts to better respond to a pandemic in the future.
Eligibility
Healthy volunteers accepted
Inclusion Criteria: * Pulmonologists that are members of the American Association of Bronchology and Interventional Pulmonology (AABIP) and/or the American College of Chest Physicians (ACCP) * These organizations were chosen because their member databases are composed of pulmonologists in the United States (U.S.) that perform the pulmonary procedures described in this survey. Letters of approval will be obtained from these organizations and provided to the MD Anderson Institutional Review Board (IRB). Once the MD Anderson IRB approves this survey study, the survey will be sent to the relevant subcommittees of these organizations for their electronic dissemination to their membership Exclusion Criteria: None
Conditions5
COVID-19 InfectionCancerHematopoietic and Lymphoid Cell NeoplasmLung CancerMalignant Solid Neoplasm
Locations1 site
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorM.D. Anderson Cancer Center
Started2020-11-11
Est. completion2027-02-02
Eligibility
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT05022446